Super Connect For Good Competition 2021
Created by alina@medisieve.co.uk on 9/30/2021 12:52:59 PM


Empact Ventures

Online, 30th September 2021

print
The comment feature is locked by administrator.
Sort by:

Latest News

MediSieve Announces Positive Final Results from Phase 1 Clinical Trial of its Magnetic Blood Filtration Platform

MediSieve Announces Positive Final Results from Phase 1 Clinical Trial of its Magnetic Blood Filtration Platform
December 07, 2022

Magnetic Blood Filtration Platform shown to be safe and well tolerated, with no serious adverse events. Investigators recommend further development of the Platform, which has a range of potential clinical applications in inflammation, oncology, gene therapies and others. ...
MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study

MediSieve Announces First Volunteer Successfully Enrolled in Phase 1 Clinical Study
July 08, 2022

Radboud University Medical Center is Conducting Safety Evaluation of MediSieve’s Magnetic Haemofiltration System for the Treatment of Acute Hyperinflammation.